QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced the launch of the QIAprep& Plasmodium Kit and two companion assays to support malaria research and surveillance efforts.
The malaria parasite, Plasmodium falciparum, however, is an entirely more challenging pathogen because it is such a large and complex organism compared to a virus. At the Proteo-Science Center at ...
Plasmodium falciparum has shown an ability to evade everything we throw at it, most recently artemisinin-based combination therapies, today’s front-line treatment. Natalie Slivinski This person does ...
Hosted on MSN6mon
Private hospitals report rise in malaria cases in Punea protozoal parasite and a few cases of Plasmodium Falciparum, a unicellular protozoan parasite, said the officials. Dr Ameet Dravid, infectious diseases expert at Noble Hospital, said ...
Ph.D. in Natural Sciences, Georgetown University, Washington D.C. Masters Thesis: 1988 "Detection of antibodies to a defined malarial antigen in humans exposed to Plasmodium falciparum" Ph. D. Thesis: ...
Malaria remains a major global health threat, with more than 250 million cases and 600,000 deaths in 2024 over 90% of them in Africa QIAprep& Plasmodium Kit enables streamlined detection ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback